|
CA3038679A1
|
|
Antibodies that bind interleukin-2 and uses thereof
|
|
EP3490600A1
|
|
Parathyroid hormone receptor 1 (pth1r) antibodies and uses thereof
|
|
AU2016304588A1
|
|
Antibody fragments against the insulin receptor and uses thereof to treat hypoglycemia
|
|
AU2015203141A1
|
|
Methods for the treatment of gout
|
|
WO2014105849A1
|
|
Antibodies specific for fgfr4 and methods of use
|
|
AU2013203560A1
|
|
Cardiovascular related uses of IL-1beta antibodies and binding fragments thereof
|
|
AU2013203557A1
|
|
Insulin receptor binding antibodies
|
|
AU2010253924A1
|
|
Cardiovascular related uses of IL-1beta antibodies and binding fragments thereof
|
|
AU2009289545A1
|
|
Methods for improvement of beta cell function
|
|
AU2009256072A1
|
|
Methods for the treatment of rheumatoid arthritis
|
|
AU5292300A
|
|
Therapeutic uses of bpi protein products in humans with otitis media with effusion
|
|
US6242219B1
|
|
Methods for recombinant peptide production
|
